Compounded Semaglutide vs. Tirzepatide: Which Is Better for Midlife Women?
The Josie Team
Health & Wellness Editors
Both compounded semaglutide and tirzepatide are effective GLP-1 options — but they work differently. Here's how to think about the choice if you're a woman in perimenopause or menopause.
The Core Difference
Semaglutide acts on one receptor (GLP-1). Tirzepatide acts on two — GLP-1 and GIP. Because it targets an additional pathway involved in fat metabolism and insulin signalling, tirzepatide tends to produce greater weight loss in head-to-head comparisons. The SURMOUNT clinical trial showed average weight loss of up to 22% with tirzepatide, compared to 15–17% with semaglutide in the STEP trials.
But averages don't tell the whole story, especially for women navigating hormonal changes. Here's a practical breakdown.
Effectiveness in Midlife Women
Both medications work well for women in perimenopause and menopause. The additional GIP receptor activity in tirzepatide may offer metabolic advantages as estrogen declines — GIP has a role in fat storage regulation that becomes more relevant when estrogen is no longer providing metabolic protection. That said, semaglutide produces clinically significant weight loss for the vast majority of users and has a longer safety record.
Side Effect Profile
The most common side effects of both medications are nausea, constipation, and fatigue, particularly in the early weeks. These effects are dose-dependent and typically improve as your body adjusts. Some women find tirzepatide causes more nausea initially; others tolerate it better than semaglutide. There's no reliable way to predict your individual response — this is something you discover and manage with your Josie provider.
Microdosing: A Midlife-Specific Option
Josie offers microdosing protocols for both medications — using lower doses than the standard clinical titration schedule. Microdosing is particularly popular with midlife women who want metabolic and appetite benefits with fewer side effects, or who are combining GLP-1 therapy with HRT and want a gentler introduction.
Cost Considerations
Compounded versions of both medications are significantly more affordable than brand-name GLP-1s. Josie's compounded semaglutide and tirzepatide are dispensed through licensed pharmacies and priced to make long-term treatment accessible.
How to Choose
If you want the highest average weight loss potential and are comfortable with a newer dual-receptor medication: consider tirzepatide. If you want the longer safety track record, wider clinical evidence base, or have tried tirzepatide and not tolerated it well: semaglutide is an excellent option. Your Josie provider will help you weigh these factors against your personal health history.
Related Articles
The Complete Guide to GLP-1 Weight Loss for Women in Menopause
Menopause changes everything — your hunger, your metabolism, your fat distribution. Here's how GLP-1 medications work with your body through this transition, not against it.
Can GLP-1s Help With PCOS Weight Gain?
PCOS-related weight gain has a hormonal root cause that dieting can't fix on its own. GLP-1 medications address several of the underlying mechanisms — here's what the evidence shows.